Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have come to the emergency department with sudden shortness of breath, and there is no other clear reason found for it (such as a collapsed lung, a new lung infection, a heart attack, or Covid-19)
- You are affiliated with the French social security system (note: AME coverage does not qualify)
- You have read the information about the trial and signed a consent form agreeing to take part
Who may not be able to join:
- You have a known long-term liver condition, including liver scarring (fibrosis) or a blood clotting result that suggests serious liver problems
- You have any open wounds or skin damage on your abdomen (belly area) where the liver scan device would be used
- You have previously had a liver transplant
- Your kidneys are not working well enough (based on a specific kidney function measurement — confirm with trial site)
- You are under a legal guardianship or protection order, or you are not free to make your own decisions (such as being in custody)
- You are currently pregnant or breastfeeding
- You are already taking part in another clinical trial that involves an intervention or treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amélie VROMANT, Medical Doctor, Assistance Publique - Hôpitaux de Paris
Phone: +33617253512
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Area under the Receiving Operator Characteristic curve (AUC ROC) of Liver Stiffness Measurement (LSM) value to diagnose AHF. Other diagnostic performances will also be assessed at the threshold determined by Youden's method.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.